April 2023 Prescription Drug Affordability Board Meeting

• Date and time: April 18th, 2023 2:00 pm

Public Comment

The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected]​ no later than the close of business on Friday, April 14, 2023, and provide:

1. Your name
2. Your address
3. The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.

Written Comment

The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]. Please submit any written comments concerning this agenda no later than the close of business on Friday, April 14, 2023.

Agenda and Meeting Materials

• Agenda - PDF - 83.93 KB
• Minutes - PDF - 150.65 KB
• PDAB Cost Review Regulations Presentation (Updated on 04/17/2023) - PDF - 375.56 KB

Draft Regulations

The Board is accepting written comments on the following draft regulations through May 2, 2023. Please submit all comments to [email protected].

Draft Proposed Regulations for Comment

• COMAR 14.01.01.01 – General Provisions (Definitions- NEW) - PDF - 89.29 KB
  • Written Comments due by May 2, 2023
• COMAR 14.01.02.02 – Prescription Drug Affordability Fund (Fee Assessment, Exemption, Waiver, and Collection) Amendments - PDF - 88.19 KB
  • Written Comments due by May 2, 2023
• COMAR 14.01.03.01-05 – (Cost Review Process) - PDF - 117.62 KB
  • Written Comments due by May 2, 2023